Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Wednesday 04 December, 2019

Morgan Stanley Cap

Rule 38.5 - Replacement of ABBVIE INC.

RNS Number : 7124V
Morgan Stanley Capital Services LLC
04 December 2019
 

AMENDMENT   Section (2b)

 

 FORM 38.5

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)

 

DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS

 

1.             KEY INFORMATION

 Name of exempt market-maker

   Morgan Stanley Capital Services LLC

 Company dealt in

   ABBVIE INC.

 Class of relevant security to which the dealings being disclosed relate (Note 1)

  US$0.01 COMMON STOCK

 Date of dealing

   02 DECEMBER 2019

 

 

2.             DEALINGS (Note 2)

 

(a)           Purchases and sales

 Total number of relevant secuities accquired

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  26,758

 87.9700 USD

 87.0300 USD

 

 Total number of relevant secuities disposed

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  10,738

 88.0200 USD

 87.0300 USD

 

 

(b)           Derivatives transactions (other than options transactions)

 

 Product name, e.g. CFD

 Nature of transaction

                (Note 4)

 Number of relevant securities

                (Note 5)

 Price per unit

 CFD

 LONG

 100

 87.3000 USD

 CFD

 LONG

 195

 87.7543 USD

 CFD

 LONG

 400

 87.8800 USD

 CFD

 SHORT

 4,330

 87.0300 USD

 CFD

 SHORT

 1,288

 87.0300 USD

 CFD

 SHORT

 26

 87.0300 USD

 CFD

 SHORT

 8

 87.0300 USD

 CFD

 SHORT

 27

 87.0300 USD

 CFD

 SHORT

 400

 87.2551 USD

 CFD

 SHORT

 1,600

 87.2551 USD

 CFD

 SHORT

 2,700

 87.2733 USD

 CFD

 SHORT

 400

 87.2733 USD

 CFD

 SHORT

 400

 87.3565 USD

 CFD

 SHORT

 300

 87.3565 USD

 CFD

 SHORT

 2,500

 87.3565 USD

 CFD

 SHORT

 400

 87.3566 USD

 CFD

 SHORT

 173

 87.3649 USD

 CFD

 SHORT

 2,194

 87.3649 USD

 CFD

 SHORT

 500

 87.4380 USD

 CFD

 SHORT

 858

 87.4412 USD

 CFD

 SHORT

 42

 87.4412 USD

 CFD

 SHORT

 927

 87.5000 USD

 CFD

 SHORT

 173

 87.5592 USD

 CFD

 SHORT

 340

 87.6106 USD

 CFD

 SHORT

 69

 87.6431 USD

 CFD

 SHORT

 340

 87.6431 USD

 CFD

 SHORT

 50

 87.8500 USD

 

 

(c)            Options transactions in respect of existing relevant securities

 

i)           Writing, selling, purchasing or varying

 

 Product name, eg call option

 Writing, selling, purchasing, varying etc

 Number of securities to which the option relates (Note 5)

 Exercise Price

 Type, e.g American, European etc

 Expiry Date

 Option money paid/received per unit (Note 3)

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercising

 

 Product name, eg call option

 Number of securities

 Exercise price per unit (Note 3)

 N/A

 N/A

 N/A 

 

 

3. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 Date of disclosure

 04 DECEMBER 2019

 Contact Name

Craig Horsley

 Telephone Number

+44(141) 245 7736

 Name of offeree/offeror with which connected

ABBVIE INC.

Nature of connection (Note 6)

Advisory

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEBLBDDDBGBGCS

a d v e r t i s e m e n t